|
|
|
|
LEADER |
01978nam a22003495i 4500 |
001 |
000293543 |
005 |
20210610113457.0 |
007 |
cr nn 008mamaa |
008 |
130321s2013 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461462200
|
024 |
7 |
|
|a 10.1007/978-1-4614-6220-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
4 |
|a The Hippo Signaling Pathway and Cancer /
|c edited by Moshe Oren, Yael Aylon.
|
250 |
|
|
|a 1st ed. 2013.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2013.
|
300 |
|
|
|a VI, 354 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Introduction -- Merlin and Angiomotin in Hippo-Yap signaling -- MST1/2 and other upstream signaling that affect Hippo pathway function -- YAP1 uses its modular protein domains and conserved sequence motifs to orchestrate diverse repertoires of signaling -- Regulation of YAP and TAZ transcription co-activators -- Regulation of YAP and TAZ by epithelial plasticity -- Hippo pathway and apoptosis -- YAP and p73: a matter of mutual specificity in tumour suppression -- The c-Abl/YAP/p73 apoptotic module and the Hippo pathway -- Hippo in cell cycle and mitosis -- Hippo and mouse models for cancer -- Roles of Hippo signaling during mouse embryogenesis -- Hippo Signaling and stem cells -- Hippo signaling and organ size control -- Hippo signaling in heart development -- Cell competition and the Hippo pathway -- Non-canonical roles from the Hippo pathway -- Index.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Cell biology.
|
650 |
|
0 |
|a Medical microbiology.
|
650 |
|
0 |
|a Medicine.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Cell Biology.
|
650 |
2 |
4 |
|a Medical Microbiology.
|
650 |
2 |
4 |
|a Biomedicine, general.
|
700 |
1 |
|
|a Oren, Moshe.
|e editor.
|
700 |
1 |
|
|a Aylon, Yael.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|